상세 보기
Real-world efficacy of first-line nivolumab plus ipilimumab and its practical predictive biomarkers in advanced renal cell carcinoma: First analysis from RENOIR study [KCSG GU22-13]
- Kim, J. H.;
- Shin, S. J.;
- Bae, W. K.;
- Kim, S. H.;
- Kim, J. Y.;
- ... Kim, D.;
- 외 14명
Citations
WEB OF SCIENCE
1- 제목
- Real-world efficacy of first-line nivolumab plus ipilimumab and its practical predictive biomarkers in advanced renal cell carcinoma: First analysis from RENOIR study [KCSG GU22-13]
- 저자
- Kim, J. H.; Shin, S. J.; Bae, W. K.; Kim, S. H.; Kim, J. Y.; Im, H-S.; Kim, I-H.; Kim, I-H.; Park, K.; Kim, E.; Choi, M.; Lim, J. H.; Kim, H.; Kim, H-J.; Jo, J.; Lee, H. J.; Kim, D.; Sohn, B. S.; Park, I.; Park, J. H.
- 발행일
- 2024-09
- 유형
- Meeting Abstract
- 권
- 35
- 호
- S2
- 페이지
- S1026 ~ S1026